Overview

Gender

male

Investor Type

Investment Partner

Greg S. Yap has been a Partner at Menlo Ventures since October 11, 2017. Greg Yap leads investments in health, medical and life sciences technologies. He served as Chief Executive Officer at Biodesy, Inc. since October 17, 2013. Greg Yap served as Vice President for DNA Products and Vice President of Molecular Diagnostics at Affymetrix Inc. Greg Yap led the DNA analysis business, where he was responsible for building products to study the human genome and the importance of genetic differences between people. He served as Chief Operating Officer at CELLective Dx.